Cat.#: ACPP-1279
| Despition | NEDD4 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1705 | Human NXPH1 Protein (AC1705) | 5 µg | inquiry |
| ACPP-1754 | Human VEGFC Protein, Sf9 (AC1754) | 2 µg | inquiry |
| ACPP-1648 | Human RAMP1 Protein (AC1648) | 2 µg | inquiry |
| ACPP-1208 | beta Catenin Blocking Peptide (AC1208) | 250 µg | inquiry |
| ACPP-1121 | Recombinant Human GFAP Protein (AC1121) | 25 µl | inquiry |
| ACPP-1679 | Human SYT4 Protein (AC1679) | 2 µg | inquiry |
| ACPP-1251 | EAAT2 Blocking Peptide (AC1251) | 250 µg | inquiry |
| ACPP-1206 | ELOVL4 Blocking Peptide (AC1206) | 250 µg | inquiry |
| ACPP-1237 | CRMP1 Blocking Peptide (AC1237) | 250 µg | inquiry |
| ACPP-1004 | Synthetic Nanodisc Human GPCR GPR20 Protein (AC1004) | 10 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.